Gilead's $21 billion purchase of Immunomedics boosts ADC field
Tuesday, September 15, 2020 - 17:10
in Mathematics & Economics
The acquisition expands the big biotech's oncology portfolio into solid tumors
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via